These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Feasibility and image quality of dual-isotope SPECT using 18F-FDG and (99m)Tc-tetrofosmin after acipimox administration. Kam BL, Valkema R, Poldermans D, Bax JJ, Reijs AE, Rambaldi R, Boersma E, Rietveld T, Roelandt JR, Krenning EP. J Nucl Med; 2003 Feb; 44(2):140-5. PubMed ID: 12571201 [Abstract] [Full Text] [Related]
3. Optimal metabolic conditions during fluorine-18 fluorodeoxyglucose imaging; a comparative study using different protocols. Bax JJ, Veening MA, Visser FC, van Lingen A, Heine RJ, Cornel JH, Visser CA. Eur J Nucl Med; 1997 Jan; 24(1):35-41. PubMed ID: 9044874 [Abstract] [Full Text] [Related]
4. Enhancement of myocardial [fluorine-18]fluorodeoxyglucose uptake by a nicotinic acid derivative. Knuuti MJ, Yki-Järvinen H, Voipio-Pulkki LM, Mäki M, Ruotsalainen U, Härkönen R, Teräs M, Haaparanta M, Bergman J, Hartiala J, Wegelius U, Nuutila P. J Nucl Med; 1994 Jun; 35(6):989-98. PubMed ID: 8195886 [Abstract] [Full Text] [Related]
12. Validation of QGS and 4D-MSPECT for quantification of left ventricular volumes and ejection fraction from gated 18F-FDG PET: comparison with cardiac MRI. Schaefer WM, Lipke CS, Nowak B, Kaiser HJ, Reinartz P, Buecker A, Krombach GA, Buell U, Kühl HP. J Nucl Med; 2004 Jan; 45(1):74-9. PubMed ID: 14734676 [Abstract] [Full Text] [Related]
13. Positron emission tomography for the assessment of myocardial viability: an evidence-based analysis. Medical Advisory Secretariat. Ont Health Technol Assess Ser; 2005 Jan; 5(16):1-167. PubMed ID: 23074467 [Abstract] [Full Text] [Related]
14. Tc-99m tetrofosmin tomography after nitrate administration in patients with ischemic left ventricular dysfunction: relation to metabolic imaging by PET. He W, Acampa W, Mainolfi C, Menna F, Sorrentino AR, Petretta M, Cuocolo A. J Nucl Cardiol; 2003 Jan; 10(6):599-606. PubMed ID: 14668771 [Abstract] [Full Text] [Related]
15. Uncoupling of fatty acid and glucose metabolism in malignant lymphoma: a PET study. Nuutinen J, Minn H, Bergman J, Haaparanta M, Ruotasalainen U, Laine H, Knuuti J. Br J Cancer; 1999 May; 80(3-4):513-8. PubMed ID: 10408861 [Abstract] [Full Text] [Related]
16. Phase analysis by gated F-18 FDG PET/CT for left ventricular dyssynchrony assessment: a comparison with gated Tc-99m sestamibi SPECT. Wang L, Wei HX, Yang MF, Guo J, Wang JF, Fang W, Wang YT. Ann Nucl Med; 2013 May; 27(4):325-34. PubMed ID: 23371445 [Abstract] [Full Text] [Related]
17. FDG imaging should be considered the preferred technique for accurate assessment of myocardial viability: against. Cuocolo A. Eur J Nucl Med Mol Imaging; 2005 Jul; 32(7):832-5. PubMed ID: 15895227 [No Abstract] [Full Text] [Related]
18. Low-carbohydrate diet versus euglycemic hyperinsulinemic clamp for the assessment of myocardial viability with 18F-fluorodeoxyglucose-PET: a pilot study. Soares J, Rodrigues Filho F, Izaki M, Giorgi MC, Catapirra RM, Abe R, Vinagre CG, Cerri GG, Meneghetti JC. Int J Cardiovasc Imaging; 2014 Feb; 30(2):415-23. PubMed ID: 24253855 [Abstract] [Full Text] [Related]
19. Acipimox does not augment thallium-201 redistribution in the fasting state. Gunning MG, Clunie G, Yepes-Mora S, Eastick S, Underwood SR, Bomanji J, Ell PJ. J Nucl Cardiol; 1999 Feb; 6(6):620-5. PubMed ID: 10608589 [Abstract] [Full Text] [Related]
20. Comparison of 99mTc-sestamibi/18FDG DISA SPECT with PET for the detection of viability in patients with coronary artery disease and left ventricular dysfunction. Slart RH, Bax JJ, de Boer J, Willemsen AT, Mook PH, Oudkerk M, van der Wall EE, van Veldhuisen DJ, Jager PL. Eur J Nucl Med Mol Imaging; 2005 Aug; 32(8):972-9. PubMed ID: 15824927 [Abstract] [Full Text] [Related] Page: [Next] [New Search]